NCT00001810View on ClinicalTrials.gov

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 1999

Study Completion Date

October 31, 2000

Conditions
AspergillosisCandidiasisFungemiaMycoses
Interventions
DRUG

Voriconazole

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH